HUIYU PHARMACEUTICAL
68855310.454.60% ( +0.46 )
HUIYU PHARMACEUTICAL (688553)
Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug pro...
- Open
- 10.05
- High
- 10.58
- Low
- 10.05
- Prev. Close
- 9.99
- Volume
- 134.50K
- Turnover
- 139.45M
- Avg Price
- 10.37
- Bid/Ask Ratio
- 11.54%
- Amplitude
- 5.31%
- 52wk High
- 18.91
- Volume Ratio
- 0.55
- Turnover Ratio
- 2.65%
News
- PUBT · Jul 22 at 09:52 AM
TYK Medicines sues Huiyu Pharma over disputed TY-9591 cooperation deal
- Wallstreetcn · Apr 8 at 10:30 PM
Midday Market Review on April 9: SSE Index Drops 0.73% in Half-Day, Computing Power Hardware Stocks Strengthen Against the Trend
- 36Kr · Nov 27, 2025 at 03:11 AM
HUIYU PHARMACEUTICAL: Plans to collaborate with professional institutions to establish a private equity fund, primarily investing in the biomedical field
- Zhitong · Oct 28, 2025 at 05:32 AM
HUIYU PHARMACEUTICAL: The company participates in the national centralized drug procurement and intends to be selected
- Zhitong · Oct 10, 2025 at 03:38 AM
HUIYU PHARMACEUTICAL: Shareholder Huang Qianyi's shares in the company have been judicially frozen and pending frozen
- Zhitong · Oct 9, 2025 at 03:19 AM
HUIYU PHARMACEUTICAL: Injectable Paclitaxel (Albumin-Bound) Obtains Overseas Listing License
